WallStreetZenWallStreetZen
Analyst Ranking
Bottom 2%
#4189 out of 4237 analysts
Average Return
-22.76%
Win Rate
23%5 out of 22
Risk vs Reward
Poor
Good

Frank Takkinen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Apyx Medical CorpAPYX
+252.36%$1.91$6.73
2022-12-07 -
2023-06-02
Strong Buy
Apyx Medical CorpAPYX
+25.56%$5.36$6.73
2023-05-11 -
2023-06-02
Strong Buy
Biolase IncBIOL
+8.54%$0.08$0.09
2023-05-30 -
2023-06-02
Strong Buy
Icad IncICAD
+2.36%$1.27$1.30
2023-03-28 -
2023-06-02
Strong Buy
Cvrx IncCVRX
+0.88%$12.54$12.65
2023-05-02 -
2023-06-02
Strong Buy

Frank Takkinen Analyst Color

Get additional color on Frank Takkinen's coverage of popular stocks

Frank Takkinen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biolase IncBIOL
2Strong Buy$0.40+349.44%Maintains
5 days ago
Edap Tms SaEDAP
1Strong Buy$16.00+60.64%Maintains
18 days ago
Apyx Medical CorpAPYX
2Strong Buy$6.00-10.85%Maintains
24 days ago
Cvrx IncCVRX
1Strong Buy$18.00+42.29%Maintains
a month ago
Greenbrook Tms IncGBNH
1Strong Buy$3.00+337.96%Maintains
2 months ago
Icad IncICAD
2Strong Buy$2.50+92.31%Maintains
2 months ago
Stereotaxis IncSTXS
1Strong Buy$4.00+80.18%Maintains
3 months ago
Neuropace IncNPCE
1Strong Buy$10.00+143.31%Initiates Coverage On
3 months ago
Pavmed IncPAVM
2Strong Buy$1.50+238.60%Maintains
5 months ago
Inotiv IncNOTV
4Strong Buy$10.00+66.94%Upgrades
5 months ago
Apollo Endosurgery IncAPEN
2Hold$10.000.00%Downgrades
6 months ago
Artivion IncAORT
1Strong Buy$32.00+109.29%Initiates Coverage On
10 months ago
Uphealth IncUPH
1Hold$10.00N/ADowngrades
a year ago
Biotricity IncBTCY
1Strong Buy$5.00N/AInitiates Coverage On
a year ago
Science 37 Holdings IncSNCE
1Strong Buy$15.00N/AInitiates Coverage On
2 years ago
Skylight Health Group IncSLHGF
1Strong Buy$8.00N/AInitiates Coverage On
2 years ago
Clearpoint Neuro IncCLPT
1Strong Buy$32.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.